Nitric oxide-derived nitrosating species and gene expression in human monocytic cells

Biochemistry

Volumn 43, Issue 33, 2004, Pages 10844-10850

  Turpaev, Kyril ^a,b   Bouton, Cécile ^a   Drapier, Jean Claude ^a  

^a CNRS   (France)

^b ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CELLS; CONCENTRATION (PROCESS); METABOLITES; OXIDATION;

NITRONYL NITROXIDE; REACTIVE NITROGEN INTERMEDIATES (RNI);

GENES;

2 PHENYL 4,4,5,5 TETRAMETHYLIMIDAZOLE 1 OXYL 3 OXIDE; 4,5 DIAMINOFLUORESCEIN; FLUORESCEIN DERIVATIVE; GLUTATHIONE; HEME OXYGENASE 1; IMIDAZOLE DERIVATIVE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NITRIC OXIDE; NITRONYL NITROXIDE; NITROXIDE DERIVATIVE; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P21; REACTIVE NITROGEN SPECIES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; METABOLITE; MONOCYTE; NITROSATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

CELL LINE; CYCLIC N-OXIDES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE EXPRESSION REGULATION; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; IMIDAZOLES; INTERLEUKIN-8; MEMBRANE PROTEINS; MONOCYTES; NITRIC OXIDE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4143062462     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi049831y     Document Type: Article

References (35)

1. Moncada, S., and Higgs, E. A. (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide, FASEB J. 9, 1319-1330.
2. Grisham, M. B., Jourd'Heuil, D., and Wink, D. A. (1999) Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. 276, G315-G321.
3. Marshall, H. E., Merchant, K., and Stamler, J. S. (2000) Nitrosation and oxidation in the regulation of gene expression, FASEB J. 14, 1889-1900.
4. Bogdan, C. (2001) Nitric oxide and the regulation of gene expression, Trends Cell Biol. 11, 66-75.
5. Stamler, J. S., Singel, D. J., and Loscalzo, J. (1992) Biochemistry of nitric oxide and its redox-activated forms, Science 258, 1898-1892.
6. O'Donnell, V. B., Coles, B., Lewis, M. J., Crews, B. C., Marnett, L. J., and Freeman, B. A. (2000) Catalytic consumption of nitric oxide by prostaglandin H synthase-1 regulates platelet function, J. Biol Chem. 275, 38239-38244.
7. Henry. Y., Lepoivre, M., Drapier, J. C., Ducrocq, C., Boucher, J. L., and Guissani, A. (1993) EPR characterization of molecular targets for NO in mammalian cells and organelles, FASEB J. 12, 1124-1134.
8. Drapier, J. C. (1997) Interplay between NO and (Fe-S) clusters: relevance to biological systems, Methods 11, 319-329.
9. Ballou, D. P., Zhao, Y., Brandish, P. E., and Marietta, M. A. (2002) Revisiting the kinetics of nitric oxide (NO) binding to soluble guanylate cyclase: the simple NO-binding model is incorrect, Proc. Natl. Acad. Sci U.S.A. 99, 12097-12101.
10. Kirsch, M., Korth, H. G., Sustmann, R., and de Groot, H. (2002) The pathobiochemistry of nitrogen dioxide, Biol. Chem. 383, 389-399.
11. 2 within the hydrophobic interior of biological membranes, Proc. Natl. Acad. Sci U.S.A. 95, 2175-2179.
12. 2 in S-nitrosylation of the channel, J. Biol. Chem. 278, 8184-8189.
13. Zech, B., Kohl, R., Von Knethen, A., and Brüne, B. (2003) Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases, Biochem. J. 371, 1055-1064.
14. Jacobs, A. T., and Ignarro, L. J. (2003) Nuclear factor-κB and mitogen-activated protein kinases mediate nitric oxide-enhanced transcriptional expression of interferon-γ, J. Biol. Chem. 278, 8018-8027.
15. Immenschuh, S., Hinke, V., Ohlmann, A., Gifhorn-Katz, S., Katz, N., Jungermann, K., and Kietzmann, T. (1998) Transcriptional activation of the heme oxygenase-1 gene by cGMP via a cAMP response element/activator protein-1 element in primary cultures of rat hepatocytes, Biochem. J. 334, 141-146.
16. von Knethen, A., Callsen, D., and Brüne, B. (1999) NF-κB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages, Mol. Biol. Cell 10, 361-372.
17. Deora, A. A., Win, T., Vanhaesebroeck, B., and Lander, H. M. (1998) A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3′-kinase to Ras by redox stress, J. Biol. Chem. 273, 29923-29928.
18. Wang, S., Van, L., Wesley, R. A., and Danner, R. L. (1997) Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP, J. Biol. Chem. 272, 5959-5965.
19. Espey, M. G., Miranda, K. M., Thomas, D. D., and Wink, D. A. (2001) Distinction between nitrosating mechanisms within human cells and aqueous solution, J. Biol. Chem. 276, 30085-30091.
20. Ziegler-Heitbrock, H. W. L., Thiel, E., Fütterer, A., Herzog, V., and Wirtz, A. (1988) Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes, Int. J. Cancer 47, 456-461.
21. Akaike, T., Yoshida, M., Miyamoto, Y., Sato, K., Kohno, M., Sasamoto, K., Miyazaki, K., Ueda, S., and Maeda, H. (1993) Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/NO through a radical reaction, Biochemistry 32, 827-832.
22. Bouton, C., and Demple, B. (2000) Nitric oxide-inducible expression of heme oxygenase-1 in human cells. Translation-independent stabilization of the mRNA and evidence for direct action of nitric oxide, J. Biol. Chem. 275, 32688-32693.
23. 2, J. Biol. Chem. 278, 50949-50955.
24. Okamoto, T., Akaike, T., Nagano, T., Miyajima, S., Suga, M., Ando, M., Ichimori, K., and Maeda, H. (1997) Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide, Arch. Biochem. Biophys. 342, 261-274.
25. Xiong, Q., Shi, Q., Le, X., Wang, B., and Xie, K. (2001) Regulation of interleukin-8 expression by nitric oxide in human pancreatic adenocarcinoma, J. Interferon Cytokine Res. 21, 529-537.
26. Bauer, P. M., Buga, G. M., Fukuto, J. M., Pegg, A. E., and Ignarro, L. J. (2001) Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme, J. Biol. Chem. 276, 34458-34464.
27. Jourd'heuil, D., Jourd'heuil, F. L., and Feelisch, M. (2003) Oxidation and nitrosation of thiols at low micromolar exposure to nitric oxide. Evidence for a free radical mechanism, J. Biol. Chem. 278, 15720-15726.
28. Sumbayev, V. V., Budde, A., Zhou, J., and Brüne, B. (2003) HIF-1 α protein as a target for S-nitrosation, FEBS Lett. 535, 106-112.
29. Garg, A. K., and Aggarwal, B. B. (2002) Reactive oxygen intermediates in TNF signaling, Mol. Immunol. 39, 509-517.
30. Villarete, L. H., and Remick, D. G. (1996) Transcriptional and post-transcriptional regulation of interleukin-8, Am. J. Pathol. 149, 1685-1693.
31. Turpaev, K., Litvinov, D., and Justesen, J. (2003) Redox modulation of NO-dependent induction of interleukin 8 gene in monocytic U937 cells, Cytokine 30, 15-22.
32. Ryter, S. W., and Tyrrell, R. M. (2000) The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties, Free Radical Biol. Med. 28, 289-309.
33. Ishida, A., Sasaguri, T., Miwa, Y., Kosaka, C., Taba, Y., and Abumiya T. (1999) Tumor suppressor p53 but not cGMP mediates NO-induced expression of p21(Waf1/Cip1/Sdi1) in vascular smooth muscle cells, Mol. Pharmacol. 56, 938-546.
34. Shaulian, E., and Karin, M. (2001) AP-1 in cell proliferation and survival, Oncogene 20, 2390-2400.
35. Hofseth, L. J., Saito, S., Hussain, S. P., Espey, M. G., Miranda, K. M., Araki, Y., Jhappan, C., Higashimoto, Y., He, P., Linke, S. P., Quezado, M. M., Zurer, I., Rotter, V., Wink, D. A., Appella, E., and Harris C. C. (2003) Nitric oxide-induced cellular stress and p53 activation in chronic inflammation, Proc. Natl. Acad. Sci. U.S.A. 100, 143-148.